TNYA
Tenaya Therapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$0.82+0.15%
Price as of Jul 20, 2026
TNYA growth
Tenaya Therapeutics, Inc. growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- —
- EBITDA
- +23.5%
- EBIT
- +21.8%
- EPS
- +59.5%
- Free cash flow
- +24.7%
- Operating cash flow
- +24.2%
Forward estimates
- Revenue
- —
- EBITDA
- —
- EPS
- +42.6%
Three-year CAGR
- Revenue
- —
- EBITDA
- +20.0%
- EBIT
- +19.5%
- Net income
- +18.5%
- EPS
- +55.0%
- Free cash flow
- +24.7%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.